Related Experiment Videos
Practical considerations in the use of apomorphine injectable.
1Jubilee Day Hospital, North Tyneside General Hospital, Tyne and Wear, United Kingdom.
Neurology
|March 24, 2004
Summary
This guide details apomorphine subcutaneous injectable therapy initiation for Parkinson's disease. Proper patient education, pre-treatment assessment, and timely injections are crucial for managing "off" periods and minimizing side effects.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease management often requires advanced therapies.
- Apomorphine offers a subcutaneous injectable option for managing motor fluctuations.
Purpose of the Study:
- To provide practical guidelines for initiating apomorphine subcutaneous injectable therapy.
- To outline patient education, pre-treatment assessment, dosage titration, and side-effect management.
Main Methods:
- Pre-treatment assessment and optimization of oral therapies.
- Apomorphine challenge to determine responsiveness and guide dosing.
- Patient and caregiver education on therapy benefits and device operation.
Main Results:
- Optimal timing of injections is critical to avert "off" periods.
- Apomorphine challenge helps establish individual dosage and identify potential side effects.
- Common side effects include nausea, somnolence, and dyskinesia; rarer effects include behavioral disturbances and skin nodules.
Conclusions:
- Careful patient selection and education are vital for successful apomorphine therapy.
- Managing "off" periods requires understanding symptom onset and timely administration.
- Monitoring for and managing side effects is essential for patient safety and treatment adherence.